-+ 0.00%
-+ 0.00%
-+ 0.00%

BTIG Assumes Ascentage Pharma Group at Buy, Announces Price Target of $48

Benzinga·03/12/2026 10:54:01
Listen to the news
BTIG analyst Jeet Mukherjee assumes Ascentage Pharma Group (NASDAQ:AAPG) with a Buy rating and announces Price Target of $48.